Skip to main content
Elsevier

Journals in Biotechnology

Exploring genetic engineering, cell culture, and bioprocessing, this collection supports researchers and industry professionals developing new therapies, diagnostics, and sustainable bio products. It features innovative techniques, case studies, and regulatory considerations, enabling advancements in healthcare, agriculture, and environmental solutions within a rapidly evolving biotech landscape.

  • Biocatalysis and Agricultural Biotechnology

    • ISSN: 1878-8181
    Official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB)Biocatalysis and Agricultural Biotechnology is the official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB). The journal publishes high quality articles especially in the science and technology of biocatalysis, bioprocesses, agricultural biotechnology, biomedical biotechnology, and, if appropriate, from other related areas of biotechnology. The journal will publish peer-reviewed basic and applied research papers, authoritative reviews, and feature articles.The scope of the journal encompasses the research, industrial, and commercial aspects of biotechnology, including the areas of: biocatalysis; bioprocesses; food and agriculture; genetic engineering; molecular biology; healthcare and pharmaceuticals; biofuels; genomics; nanotechnology; environment and biodiversity; and bioremediation.Types of papers published are: Full-length original research papers; Short communications; Invited reviews; Letters to the Editor.
    Subscriptions

  • Trends in Biotechnology

    • ISSN: 0167-7799
    Trends in Biotechnology is a monthly journal that publishes innovative applications of biology as useful technologies. Our articles should describe biobased solutions to important problems and should emphasize how to engineer or adapt living systems for societal benefit. Specific application areas include human health and well-being, renewable energy, food and agriculture, natural resources, and production of bulk and fine chemicals. A Trends in Biotechnology article should not merely summarize lab-scale research; it should think carefully about implementation, scale-up, and “real world” implications. A key consideration is how to translate or commercialize experimental applied biology to products, industrial platforms, therapies, or devices. Scientific areas of interest include but are not limited to the following: • Synthetic biology • Genome editing • Tissue engineering and biofabrication • Metabolic engineering • Cellular and microbial engineering • Plant trait improvement and agricultural engineering • Biomanufacturing • Biosensors and bioelectronics • Biofuels, bioenergy, microbial fuel cells • Cellular agriculture and alternative nutrients/proteins Trends in Biotechnology publishes review articles, opinions, research articles, and reports (or short research articles) on these topics. We also welcome shorter commentary articles on law and intellectual property, policy and regulation, bioethics, scientific communication, and the economics of biotechnology. Additionally, we consider resource articles describing novel approaches for developing biobased technologies. Trends in Biotechnology has a diverse audience that reflects its intentionally broad scope. Our readers include biologists, engineers, chemists, pharmacologists, computer scientists, and physicians, and they work in academic, clinical, industrial, NGO, and governmental settings. Therefore, we emphasize accessible articles that are easy to read, and we encourage authors to keep in mind that many readers may not be familiar with their field's specific terminology. Visit the Cell Press website for more information about Trends in Biotechnology - https://www.cell.com...
    Subscriptions

  • Biotechnology Advances

    • ISSN: 0734-9750
    Biotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues. Authoritative articles on current developments and future trends in biotechnology are emphasized.Submissio... of appropriate manuscripts are invited. A wide audience of scientists, engineers and others is addressed: students, instructors, researchers, practitioners, managers, governments and related stakeholders. Special issues are published on selections of presentations at recent relevant conferences as arranged with the organizations.
    Subscriptions

  • Nanomedicine: Nanotechnology, Biology and Medicine

    • ISSN: 1549-9634
    Nanomedicine: Nanotechnology, Biology and Medicine (NBM) is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.Nanomedicin... Nanotechnology, Biology, and Medicine aims to promote the interdisciplinary field of nanomedicine.The journal publishes topics including:artificial cellsregenerative medicinegene therapyinfectious diseasenanotechnolog... celltissue engineeringSub-categ... include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; public health; toxicology; theranostics; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.
    Subscriptions

  • Plant Science

    • ISSN: 0168-9452
    An international journal of experimental plant biologyThis journal has no page charges, publication is free of charge.Plant Science will publish in the minimum of time, reporting significant advances in plant biology as well as commissioned reviews, method papers (technical papers) and commentaries recommended by its referees in all areas of experimental plant biology with emphasis in the broad areas of genomics, proteomics, biochemistry, physiology, cell biology, development, genetics, functional plant breeding, systems biology and the interaction of plants with the environment. Although manuscripts containing large data are welcomed, they must contain functional validation.Manuscrip... for full consideration should be written concisely and essentially as a final report. The main criterion for publication is that the manuscript must contain original and significant insights that lead to a better understanding of fundamental plant biology. Plant Science is not a publication vehicle for preliminary observations, for studies that are merely confirmatory of results accomplished in other plant systems, or that are addressed only to a specialized readership. Submitted manuscripts describing studies of preliminary nature, that are merely confirmatory in scope or of limited scope and interest to the general readership of the journal will be returned without formal review. As a general policy, the journal will no longer consider manuscripts just describing the cloning, sequencing and expression patterns of gene sequences that have been identified and characterized in other plant species, expression of a protein without proper characterization of the recombinant product and native form, the isolation, purification and characterization of enzymes extensively analyzed in other plants, description of molecular markers and plant genetic diversity without any relevant biological information, cell culture and/or transformation of plant species (or closely related species) already established in the literature and basic transcriptomic approaches with no further relevant functional characterization of genes of interest.
    Subscriptions

  • Current Opinion in Biomedical Engineering

    • ISSN: 2468-4511
    Current Opinion in Biomedical Engineering provides systematic and focused reviews of the latest developments in different areas of the field of biomedical engineering. The Journal editors invite experts to evaluate the most innovative and interdisciplinary advances published in the previous 2 years. In addition to describing recent trends, authors will provide their subjective opinion on the topics discussed.Themed Sections: Each issue will review up to two of the major themes of biomedical engineering outlined below. In doing so, the Journal will serve as an invaluable resource to help bridge knowledge gaps amongst the researchers, academics, clinicians, professionals, and students with specializations in the various sub-disciplines of this field.BiomaterialsBi... and mechanobiologyBiomed... imagingFuture of biomedical engineeringMolecular and cellular engineeringNeural engineeringNovel biomedical technologiesTissue engineering and regenerative medicineSelection of the topics to be reviewed: Section editors, who are major authorities in the field, are appointed by the Editor-in-Chief of the journal. They divide their section into a number of topics representing key subfields of the discipline, ensuring that the field is comprehensively covered and that all issues of current importance are emphasized. Section Editors, together with specialist Guest Editors, commission reviews from authorities on each topic that they have selected with the aim to stimulate exchange of ideas amongst experts. Editorial Board members are experts in the various subfields of the discipline, and support the Section Editors in the identification of important topical areas, Guest Editors, and prospective authors.Editorial Overview: Section Editors, together with the Guest Editors, will write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.
    Subscriptions

  • Next Research

    • ISSN: 3050-4759
    Next Research is a peer-reviewed multidisciplinary journal, publishing research spanning all scientific technical and medical communities.The journal is part of the Next family, a new suite of multidisciplinary journals from Elsevier spanning all branches of science. Managed by our dedicated team of in-house Editors, Next Research offers authors speed, consistency, innovation, flexibility, and ease of submission.Next Research is an inclusive venue for scientifically accurate manuscripts that meet the ethical and scientific publishing standards. It publishes all research topics across the fields of health sciences, physical sciences, life sciences and social sciences. Next Research publishes experimental, computational, and theoretical work, in traditional formats such as Original Research Articles, Communications and Reviews, as well as novel formats and video content.The journal provides authors with rigorous peer review ensuring articles adhere to a high technical standard, with rapid decisions and a highly visible platform for scientists to share their research.We believe that all rigorous research should be shared.
    Subscriptions

  • Molecular Therapy

    • ISSN: 1525-0016
    Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2024 impact factor is 12.To accommodate the rapid growth of Molecular Therapy, articles will be submitted and published in one of the following subsections (for section editors, please see the editorial board page):Biomarker and therapeutic target identificationCell therapyClinical gene and cell therapiesEpigenome editingGenome editingImmunotherapy... diagnostics and imagingNon-viral gene therapyRNA therapiesSmall-molec... therapiesVaccine developmentViral gene therapyVisit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/...
    Subscriptions

  • Metabolic Engineering

    • ISSN: 1096-7176
    An official journal of the International Metabolic Engineering Society Metabolic Engineering (MBE) is devoted to the publication of original research papers on the directed modulation of metabolic pathways for metabolite over production or the improvement of cellular properties. Papers describing native pathway engineering and synthesis of heterologous pathways for converting microorganisms into microbial cell factories are also welcome.Experimental... computational, and modelling approaches for the elucidation of metabolic pathways and their manipulation by genetic, media, or other environmental means are presented. Efficient probing of metabolic pathways requires the application of appropriate methods from molecular biology and biochemistry, along with modeling and data analysis techniques from engineering. MBE provides a forum for communicating such interdisciplinary research, as well as relevant results in the constituent areas of biochemistry, molecular biology, applied microbiology, cellular physiology, cellular nutrition in health and disease, and biochemical engineering.Types of papers: Original Research Papers, Review Papers.Authors are also welcome to submit to MBE's companion title, Metabolic Engineering Communications, which publishes shorter articles and those describing key elements of larger metabolic engineering efforts.
    Subscriptions

  • Advanced Drug Delivery Reviews

    • ISSN: 0169-409X
    The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.
    Subscriptions

Related subjects